BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reports Impressive Q2 2025 Financial Results
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameBioCryst Pharmaceuticals, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









